Get Started

AKBA

NASD Akebia Therapeutics, Inc.
Nov 3, 2026 · 1:12 PM ET DELAYED Market Open

$0.7187 ↑ +0.0103 (+1.45%) Trading Up from the previous close of $0.7084, $0.0287 below the day’s high of $0.7474

YTD change
-55.36%
vs 20-day SMA
+0.98%
vs 200-day SMA
-37.16%

Price ranges

Previous day
$0.6920 $0.7300
open $0.7100 close $0.7084
-$0.0016 (-0.23%)
Today
$0.7100 $0.7474
open $0.7247 now $0.7187
-$0.0060 (-0.83%)
Past week
$0.6345 $0.8000
from $0.6438 now $0.7187
+$0.0749 (+11.63%)
Past month
$0.5421 $0.9105
from $0.9105 now $0.7187
-$0.1918 (-21.07%)
This year
$0.5421 $1.6300
from $1.6100 now $0.7187
-$0.8913 (-55.36%)

Price & Performance

-0.79 (-52.77%) / 6M

$0.4872$0.8498$1.21$1.58May 4Aug 4Nov 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 96.5% away from all-time highs of $20.2500
  • AKBA is down 55% since the beginning of the year
  • AKBA is down 66% over the past 12 months
  • AKBA is down 21% over the past 1 month
  • 9% of all AKBA investors are betting against AKBA

AKBA reads not so good: price sits above one of the two key moving averages, the 12-month move is -66.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.03
Earnings momentum +16.6% Quarterly EPS growth
Quarterly change +16.6%

Valuation

P/E ratio N/A
Enterprise value $244.5M
Beta 0.93

Balance sheet & scale

IncomeN/A
Revenue$219.1M
Cash$157.3M
Debt$210.8K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $199.2M

Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vafseo. The company was founded by Joseph H. Gardner, John M. Rice Jr., Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,410.99 -0.46%
JNJ Johnson & Johnson $270.56 -0.97%
ABBV AbbVie, Inc. $288.84 -2.05%
MRK Merck & Co., Inc. $148.36 -0.78%
RHHBY Roche Holding Ltd Sponsored ADR $60.67 -0.98%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.